+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prognostic value of p16INK4a as a marker of clinical evolution in patients with cervical intraepithelial neoplasia grade 3 CIN 3 treated by cervical conization



Prognostic value of p16INK4a as a marker of clinical evolution in patients with cervical intraepithelial neoplasia grade 3 CIN 3 treated by cervical conization







The aim of this study was to assess the prognostic value of p16INK4a as a marker of post-conization relapse in patients treated for cervical intraepithelial neoplasia grade 3 (CIN 3). A retrospective study of 76 women with CIN 3 diagnoses, treated at the Hospital of Santa Casa de Miseric rdia of S o Paulo (Brazil) between January 2003 and September 2004, was performed. The study samples were obtained from cervical conization procedures, where paraffin blocks containing areas with the greatest amount of neoplastic tissue were selected. Immunohistochemical techniques were used on individual paraffin blocks for each case to detect p16INK4a protein expression. The p16INK4a cell counts were performed in 10 different high-amplification fields (400x) by light microscopy and total cell count expressed as number of cells per mm2. Patients involved in this study were followed up at the colposcopy outpatient unit for at least 48 months after cervical conization. The correlation of p16INK4a values with post-conization evolution in the patients (disease relapse or disease free) was determined. A significantly higher count of cells expressing p16INK4a was found in those patients with disease relapse during follow-up (p < 0.001). The variables age, number of gestations, and births correlated positively with number of cells expressing p16INK4a cells (p < 0.001; p = 0.001; 0.009, respectively). No correlation was found for the variables menopause, hormonal contraception, or smoking (p = 0.369, 0.425 and 0.853, respectively). p16INK4a can be considered a biomarker of cervical intraepithelial neoplasia grade 3 cases presenting high risk of relapse or evolution to invasive carcinoma.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036935273

Download citation: RISBibTeXText

DOI: 10.1111/apm.12130


Related references

Prognostic value of p16(INK4a) as a marker of clinical evolution in patients with cervical intraepithelial neoplasia grade 3 (CIN 3) treated by cervical conization. Apmis 122(3): 192-199, 2014

Diagnosis and treatment of grade III cervical intraepithelial neoplasia by cervical conization in 98 patients. Nan Fang Yi Ke Da Xue Xue Bao 30(7): 1642-4 1647, 2010

Evaluation of cervical conization as a definitive treatment for microinvasive cervical carcinoma and cervical intraepithelial neoplasia grade 3. Archives of Gynecology and Obstetrics 285(2): 453-457, 2012

Pregnancy outcome in patients treated with cervical conization for cervical intraepithelial neoplasia. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 112(3): 225-228, 2011

Pregnancy Outcome in Patients Treated With Cervical Conization for Cervical Intraepithelial Neoplasia. Obstetric Anesthesia Digest 32(2): 131-132, 2012

Clinical analysis of patients underwent hysterectomy for stage I cervical cancer or high grade cervical intraepithelial neoplasia with vaginal intraepithelial neoplasia. Zhonghua Fu Chan Ke Za Zhi 50(7): 516-521, 2015

Prediction of disease persistence after conization for microinvasive cervical carcinoma and cervical intraepithelial neoplasia grade 3. International Journal of Gynecological Cancer 14(2): 311-316, 2004

HPV genotyping among women treated for high-grade cervical intraepithelial neoplasia with no lesion in the conization specimen. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 129(2): 109-113, 2015

Long-term risk of cervical cancer following conization of cervical intraepithelial neoplasia grade 3-A Danish nationwide cohort study. International Journal of Cancer 142(9): 1759-1766, 2018

P16INK4A and survivin: Diagnostic and prognostic markers in cervical intraepithelial neoplasia and cervical squamous cell carcinoma. Experimental and Molecular Pathology 99(1): 44-49, 2015

Prognostic significance of immunohistochemical phenotypes in patients treated for high-grade cervical intraepithelial neoplasia. Biomed Research International 2013: 831907, 2013

Follow-up study of patients with cervical intraepithelial neoplasia grade 1 overexpressing p16Ink4a. International Journal of Gynecological Cancer 23(9): 1663-1669, 2013

P16INK4a immunoexpression: surrogate marker of high-risk HPV and high-grade cervical intraepithelial neoplasia. Advances in Anatomic Pathology 13(4): 190-194, 2006

Repeat LEEP conization in patients with cervical intraepithelial neoplasia grade 3 and positive ectocervical margins. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 105(1): 14-17, 2009

Factors associated with an increased risk of prevalent and incident grade III cervical intraepithelial neoplasia and invasive cervical cancer among women with Papanicolaou tests classified as grades I or II cervical intraepithelial neoplasia. American Journal of Obstetrics & Gynecology 186(1): 28-34, 2002